Baricitinib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2132 publications
Cost-utility and budget impact analysis of dupilumab and oral Janus kinase (JAK) inhibitors for treating moderate-to-severe atopic dermatitis in Taiwan.
Journal: Journal of medical economics
Published: January 20, 2026
T-cell-predominant inflammation in livedoid vasculopathy and response to baricitinib.
Journal: JAAD international
Published: January 19, 2026
Persistent COVID-19 Pneumonia in a Patient on Rituximab.
Journal: Journal of investigative medicine high impact case reports
Published: January 06, 2026
Azetidines in medicinal chemistry: emerging applications and approved drugs.
Journal: Future medicinal chemistry
Published: January 05, 2026
Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and diabetes reversal.
Journal: The Journal of clinical investigation
Published: January 02, 2026
Efficacy of Janus kinase inhibitor combined with phototherapy in non-segmental vitiligo: systematic review and meta-analysis.
Journal: Annals of medicine
Published: December 27, 2025
Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica
Published: December 20, 2025
Efficiency and safety of JAK inhibitors for alopecia totalis and alopecia universalis
Journal: Zhonghua yi xue za zhi
Published: December 16, 2025
Head and neck atopic Dermatitis: are janus kinase inhibitors a game changer?
Journal: Expert opinion on pharmacotherapy
Published: December 14, 2025
An oral lichen planus-like mouse model driven by IFN-γ signaling and cytotoxic CD8+ T cells.
Journal: JCI insight
Published: December 11, 2025
Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin.
Journal: Science advances
Published: December 10, 2025
Last Updated: 02/24/2026